New Key Statistics Module, Z-Score and F-Score
SHSE:600713 Key Ratios
Market Cap ¥ M | 5,564.64 |
Enterprise Value ¥ M | 14,407.44 |
P/E(ttm) | 9.36 |
PE Ratio without NRI | 9.26 |
Forward PE Ratio | -- |
Price/Book | 0.84 |
Price/Sales | 0.10 |
Price/Free Cash Flow | 6.13 |
Price/Owner Earnings | 16.41 |
Payout Ratio % | 0.31 |
Revenue (TTM) ¥ M | 53,460.00 |
EPS (TTM) ¥ | 0.45 |
Beneish M-Score | -2.46 |
10-y EBITDA Growth Rate % | 8.40 |
5-y EBITDA Growth Rate % | 16.80 |
y-y EBITDA Growth Rate % | 6.60 |
EV-to-EBIT | 10.58 |
EV-to-EBITDA | 10.58 |
PEG | 0.55 |
Shares Outstanding M | 1,309.33 |
Net Margin (%) | 1.10 |
Operating Margin % | 2.91 |
Pre-tax Margin (%) | 1.86 |
Quick Ratio | 1.13 |
Current Ratio | 1.41 |
ROA % (ttm) | 1.83 |
ROE % (ttm) | 9.28 |
ROIC % (ttm) | 6.48 |
Dividend Yield % | 3.75 |
Altman Z-Score | 2.34 |
SHSE:600713 Number of Guru Trades
SHSE:600713 Volume of Guru Trades
Gurus Latest Trades with SHSE:600713
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600713 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Pharmaceutical Co Ltd Insider Transactions
No Available Data